Dynasil Corporation of America (DYSL)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Dynasil Corporation of America (DYSL) with AI Score 43/100 (Weak). Dynasil Corporation of America develops, manufactures, and markets detection, sensing, and analysis technology, along with optical components. Market cap: 0, Sector: Technology.
Last analyzed: Mar 16, 2026Dynasil Corporation of America (DYSL) Technology Profile & Competitive Position
Dynasil Corporation of America operates in the technology sector, specializing in detection, sensing, and analysis technologies, as well as optical components. With a focus on the Optics, Innovation and Development, and Biomedical segments, the company serves medical, industrial, and security markets, distinguishing itself through specialized materials and advanced sensor development.
Investment Thesis
Dynasil Corporation of America presents a unique investment case within the technology sector, focusing on specialized optical components and detection technologies. With a market capitalization of $0.02 billion and a negative P/E ratio of -54.81, the company's current profitability is a concern, indicated by a negative profit margin of -0.9%. However, a gross margin of 36.8% suggests potential for improved profitability through operational efficiencies. Growth catalysts include expansion in the homeland security and medical sectors, driven by increasing demand for advanced detection and imaging technologies. The company's innovation in materials and sensors could lead to new product offerings and market opportunities. However, investors should be aware of the risks associated with OTC market trading and the company's negative beta of -0.22, indicating a potential inverse correlation with the market.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.02 billion, reflecting its small-cap status.
- Negative P/E ratio of -54.81, indicating current losses.
- Gross margin of 36.8%, suggesting potential for profitability improvements.
- Negative profit margin of -0.9%, highlighting current financial challenges.
- Beta of -0.22, suggesting a potential inverse correlation with the broader market.
Competitors & Peers
Strengths
- Specialized expertise in optical components and detection technologies.
- Diverse product portfolio serving multiple sectors.
- Innovation and Development segment focused on advanced technologies.
- Established customer relationships in key markets.
Weaknesses
- Small market capitalization and limited financial resources.
- Negative profitability and reliance on external funding.
- Concentration of revenue in specific sectors.
- OTC market listing, which may limit investor access.
Catalysts
- Ongoing: Increasing demand for advanced detection technologies in the homeland security sector.
- Ongoing: Growth in the medical imaging market driving demand for optical components.
- Upcoming: Potential new contracts with major customers in the security and medical sectors.
- Ongoing: Innovation in the Innovation and Development segment leading to new product offerings.
- Upcoming: Strategic partnerships and acquisitions to expand product portfolio.
Risks
- Potential: Intense competition from larger and more established companies.
- Potential: Technological obsolescence and the need for continuous innovation.
- Ongoing: Economic downturns and reduced demand for optical components.
- Ongoing: Regulatory changes and compliance requirements.
- Potential: Limited financial resources and reliance on external funding.
Growth Opportunities
- Expansion in Homeland Security Sector: The increasing need for advanced detection technologies in homeland security presents a significant growth opportunity for Dynasil. As governments worldwide invest in enhanced security measures, the demand for Dynasil's detection and sensing technologies is expected to rise. This includes applications in baggage screening, border control, and threat detection. The global homeland security market is projected to reach $650 billion by 2028, offering a substantial addressable market for Dynasil.
- Penetration of Medical Imaging Market: Dynasil's optical components are used in medical imaging systems, a market experiencing steady growth due to an aging population and increasing demand for diagnostic imaging. The company can expand its presence in this sector by developing new and improved optical solutions for medical imaging applications. The global medical imaging market is projected to reach $50 billion by 2027, providing a significant growth avenue for Dynasil.
- Development of Advanced Sensors: The Innovation and Development segment's focus on advanced sensors offers a long-term growth opportunity. By developing innovative sensors for various applications, including security, medical, and industrial, Dynasil can create new revenue streams and differentiate itself from competitors. The global sensor market is expected to reach $250 billion by 2028, presenting a substantial opportunity for Dynasil.
- Strategic Partnerships and Acquisitions: Dynasil can pursue strategic partnerships and acquisitions to expand its product portfolio, enter new markets, and gain access to new technologies. Collaborating with other technology companies or acquiring complementary businesses can accelerate Dynasil's growth and enhance its competitive position. This strategy could involve partnerships with companies specializing in related technologies or acquisitions of businesses with complementary product lines.
- Geographic Expansion: Dynasil currently serves the United States, Asia, and Europe. Expanding its geographic reach to other regions, such as South America and Africa, can unlock new growth opportunities. By establishing a presence in these emerging markets, Dynasil can tap into new customer bases and increase its overall revenue. This expansion could involve establishing sales offices, partnering with local distributors, or acquiring businesses with existing operations in these regions.
Opportunities
- Expansion in homeland security and medical imaging markets.
- Development of new and innovative sensor technologies.
- Strategic partnerships and acquisitions to expand product portfolio.
- Geographic expansion to emerging markets.
Threats
- Intense competition from larger and more established companies.
- Technological obsolescence and the need for continuous innovation.
- Economic downturns and reduced demand for optical components.
- Regulatory changes and compliance requirements.
Competitive Advantages
- Specialized Expertise: Dynasil possesses specialized expertise in the development and manufacturing of synthetic crystals and optical components.
- Proprietary Technology: The company's Innovation and Development segment focuses on creating advanced technologies in materials and sensors, potentially leading to proprietary technologies.
- Established Customer Relationships: Dynasil has established relationships with customers in various sectors, including medical, industrial, and homeland security.
- Diverse Product Portfolio: The company offers a diverse range of products and services across its Optics, Innovation and Development, and Biomedical segments.
About DYSL
Founded in 1960 and headquartered in Newton, Massachusetts, Dynasil Corporation of America develops, manufactures, and markets detection, sensing, and analysis technology and optical components. The company operates through three segments: Optics, Innovation and Development, and Biomedical. The Optics segment provides synthetic crystals, optical materials, components, and coatings crucial for devices like baggage scanners, medical imaging systems, lasers, and analytical instruments. These products cater to the medical, industrial, homeland security, and defense sectors. The Innovation and Development segment focuses on creating advanced technologies in materials, sensors, and prototype instruments designed to detect or measure radiation, light, magnetism, or sound. These innovations find applications in security, medical, and industrial fields. The Biomedical segment is involved in the development of tissue sealant products. Dynasil distributes its products through a combination of direct sales and marketing efforts, along with manufacturer's representatives and distributors, reaching customers across the United States, Asia, and Europe.
What They Do
- Develops and manufactures synthetic crystals for various applications.
- Produces optical materials, components, and coatings.
- Creates detection, sensing, and analysis technology.
- Offers advanced technology in materials and sensors.
- Develops prototype instruments for radiation, light, magnetism, and sound detection.
- Engages in the development of tissue sealant products.
- Serves the medical, industrial, and homeland security/defense sectors.
Business Model
- Sells optical components and materials to device manufacturers.
- Develops and markets detection and sensing technologies.
- Generates revenue through direct sales and marketing efforts.
- Utilizes manufacturer's representatives and distributors for product distribution.
Industry Context
Dynasil Corporation of America operates within the hardware, equipment, and parts industry, a segment of the broader technology sector. This industry is characterized by constant innovation, evolving customer needs, and intense competition. Companies in this space must continually invest in research and development to stay ahead of technological advancements. Dynasil's focus on specialized optical components and detection technologies positions it in niche markets within this industry. The company faces competition from both large, diversified technology companies and smaller, specialized firms. Market trends include increasing demand for advanced imaging and detection technologies in the medical, industrial, and security sectors.
Key Customers
- Manufacturers of baggage scanners.
- Companies producing medical imaging systems.
- Manufacturers of optical instruments and lasers.
- Automotive component manufacturers.
- Semiconductor and electronic device manufacturers.
Financials
Chart & Info
Dynasil Corporation of America (DYSL) stock price: Price data unavailable
Latest News
-
Stocks Which Set New 52-Week Low Yesterday, October 31st
· Nov 1, 2018
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for DYSL.
Price Targets
Wall Street price target analysis for DYSL.
MoonshotScore
What does this score mean?
The MoonshotScore rates DYSL's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Hardware, Equipment & PartsLeadership: Peter Sulick
CEO
Peter Sulick serves as the CEO of Dynasil Corporation of America, managing a workforce of 207 employees. His background includes extensive experience in the technology and manufacturing sectors. He has held various leadership positions in companies focused on optical components, detection technologies, and advanced materials. His expertise spans strategic planning, product development, and market expansion. He is responsible for guiding Dynasil's overall strategy and operations.
Track Record: Under Peter Sulick's leadership, Dynasil has focused on expanding its presence in the homeland security and medical imaging markets. He has overseen the development of new sensor technologies and the expansion of the company's product portfolio. Key milestones include securing contracts with major customers in the security and medical sectors and driving innovation in the Innovation and Development segment. He is focused on improving the company's profitability and financial performance.
DYSL OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Dynasil Corporation of America may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, and trading activity can be sporadic. Investing in companies on the OTC Other tier carries a higher degree of risk compared to those listed on major exchanges like NYSE or NASDAQ due to less stringent regulatory oversight and reporting requirements.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Financial Disclosure: OTC companies may have less stringent reporting requirements, making it difficult to assess their financial health.
- Low Liquidity: OTC stocks often have low trading volumes, leading to wider bid-ask spreads and potential difficulty in buying or selling shares.
- Increased Volatility: OTC stocks can be more volatile than those listed on major exchanges.
- Potential for Fraud: The OTC market has a higher risk of fraudulent activity due to less regulatory oversight.
- Limited Investor Protection: Investors in OTC stocks may have fewer legal protections compared to those investing in listed companies.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Check for any legal or regulatory issues.
- Evaluate the company's liquidity and trading volume.
- Consult with a financial advisor.
- Understand the risks associated with investing in OTC stocks.
- Longevity: Dynasil Corporation of America was founded in 1960, indicating a long history of operations.
- Established Business: The company has an established business model with multiple operating segments.
- Customer Base: Dynasil serves customers in various sectors, including medical, industrial, and homeland security.
- Employee Count: The company employs 207 people, suggesting a substantial operation.
Common Questions About DYSL
What does Dynasil Corporation of America do?
Dynasil Corporation of America develops, manufactures, and markets detection, sensing, and analysis technology, along with optical components. Operating through Optics, Innovation and Development, and Biomedical segments, the company serves diverse sectors including medical, industrial, and homeland security. The Optics segment provides synthetic crystals and optical materials, while the Innovation and Development segment focuses on advanced sensors. The Biomedical segment develops tissue sealant products, contributing to a diversified technology portfolio.
What do analysts say about DYSL stock?
As of March 16, 2026, there is no readily available analyst consensus on DYSL stock due to its OTC listing and limited coverage. Key valuation metrics such as the negative P/E ratio of -54.81 reflect current losses. Growth considerations include expansion in homeland security and medical imaging markets, balanced against risks associated with OTC trading and limited financial disclosure. Investors should conduct thorough due diligence and consult with a financial advisor before investing.
What are the main risks for DYSL?
The main risks for Dynasil Corporation of America include intense competition from larger companies, technological obsolescence, and economic downturns affecting demand for optical components. As an OTC-listed company, DYSL faces risks related to limited liquidity, increased volatility, and less stringent regulatory oversight. Financial risks include negative profitability and reliance on external funding. Investors should carefully assess these factors before investing in DYSL.
What are the key factors to evaluate for DYSL?
Dynasil Corporation of America (DYSL) currently holds an AI score of 43/100, indicating low score. Key strength: Specialized expertise in optical components and detection technologies.. Primary risk to monitor: Potential: Intense competition from larger and more established companies.. This is not financial advice.
How frequently does DYSL data refresh on this page?
DYSL prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven DYSL's recent stock price performance?
Recent price movement in Dynasil Corporation of America (DYSL) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Specialized expertise in optical components and detection technologies.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider DYSL overvalued or undervalued right now?
Determining whether Dynasil Corporation of America (DYSL) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying DYSL?
Before investing in Dynasil Corporation of America (DYSL), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available company data and may be subject to change.
- OTC market data may be less reliable than data for listed companies.